
Chris Shine
Featured in:
Articles
-
Feb 13, 2024 |
medrxiv.org | Emma Campbell |Chris Shine |Ellie Macey |Caitlin Kneebone-Hopkins
KK was Chair of the NICE Public Health Guidance (PH38) Type 2 diabetes: Prevention in people at high risk. KK has acted as a consultant, speaker or received grants for investigator-initiated studies for Astra Zeneca, Bayer, Novartis, Novo Nordisk, Sanofi-Aventis, Lilly and Merck Sharp & Dohme, Boehringer Ingelheim, Oramed Pharmaceuticals, Pfizer, Roche and Applied Therapeutics. RJ is currently employed by Diabetes UK.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →